SOURCE: Masimo

Masimo

April 23, 2015 12:14 ET

Masimo Proudly Sponsors Award-Winning Documentary "Personal Gold" During 2015-16 Film Festival Season

IRVINE, CA--(Marketwired - Apr 23, 2015) - Masimo (NASDAQ: MASI), maker of breakthrough Measure-through Motion and Low Perfusion™ pulse oximetry, announced today that it is the presenting sponsor of the award-winning documentary "Personal Gold: An Underdog Story" for the 2015-16 film festival season.

Heralded as "Miracle on Ice-meets-Moneyball" by Wall Street Journal reporter Reed Albergotti, "Personal Gold" gives a behind-the-scenes experience of four underdog women cyclists who become America's hope for a medal at the 2012 London Olympics after the men's team was banned during the Lance Armstrong drug scandal.

The underfunded women relied on pulse oximetry and other technologies as part of an innovative "Data not Doping" training regimen to do the impossible -- win the first U.S. Women's Track Cycling medal in more than 20 years.

The film features a consumer version of Masimo's pulse oximeter, released for sports and aviation.

"I use Masimo pulse oximetry as part of my training and recovery regimen," said U.S. silver medal cyclist Dotsie Bausch. "By tracking my oxygenation and pulse rate, along with numerous other biological and behavioral metrics, I use the data to measure and improve my athletic performance and gauge my recovery."

A private "sneak peek" screening of "Personal Gold" is Friday, April 24, at the Newport Beach Film Festival, followed by a Q-and-A with the filmmakers and one of the cyclists.

#mypersonalgold
@masimoinnovates
@nbff

About Masimo:
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion™ pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo.

Contact Information